Company intelligence / Profile preview

Waterdrop

Beijing, Beijing, China

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Waterdrop reported robust financial results and strong user engagement. In 2024-2025, its Waterdrop Medical Crowdfunding platform has raised RMB 70 billion for 3.54 million patients, the E-Find Patient Recruitment platform has cumulatively enrolled 12,216 patients across 1,385 clinical trial programs, and AI-driven solutions have reduced manual review costs by 50% and improved patient enrollment efficiency by 45%.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Jemincare (CKD digital service platform)177 pharmaceutical companies and CROs for clinical trial recruitmentGuangzhou Civil Affairs Bureau (Waterdrop Co-Help initiative)

Beyond the preview

Go deeper on Waterdrop.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Waterdrop.

Explore the full profile